[1] JIANG Z X, LIU J C, GUAN J, et al. Self-adjuvant effect by manipulating the bionano interface of liposome-based nanovaccines[J]. Nano Lett, 2021, 21(11): 4744-4752. doi:  10.1021/acs.nanolett.1c01133
[2] LACZKÓ D, HOGAN M J, TOULMIN S A, et al. A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice[J]. Immunity, 2020, 53(4): 724-732. e7.
[3] HUANG Q R, JI K, TIAN S Y, et al. A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2[J]. Nat Commun, 2021, 12(1): 776. doi:  10.1038/s41467-021-21037-2
[4] WEN R, UMEANO A C, KOU Y, et al. Nanoparticle systems for cancer vaccine[J]. Nanomedicine, 2019, 14(5): 627-648. doi:  10.2217/nnm-2018-0147
[5] ZHANG Y B, SUN C Z, WANG C, et al. Lipids and lipid derivatives for RNA delivery[J]. Chem Rev, 2021, 121(20): 12181-12277. doi:  10.1021/acs.chemrev.1c00244
[6] HU M, LI X, YOU Z, et al. Physiological barriers and strategies of lipid-based nanoparticles for nucleic acid drug delivery[J]. Adv Mater, 2024, 36(22): e2303266. doi:  10.1002/adma.202303266
[7] XU M, QI Y, LIU G, et al. Size-dependent in vivo transport of nanoparticles: implications for delivery, targeting, and clearance[J]. ACS Nano, 2023, 17(21): 20825-20849. doi:  10.1021/acsnano.3c05853
[8] WANG H, LIN S, WU X, et al. Interplay between liposomes and IgM: principles, challenges, and opportunities[J]. Adv Sci(Weinh), 2023, 10(20): e2301777.
[9] DIGIACOMO L, POZZI D, PALCHETTI S, et al. Impact of the protein Corona on nanomaterial immune response and targeting ability[J]. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2020, 12(4): e1615. doi:  10.1002/wnan.1615
[10] EHRENSTEIN M R, NOTLEY C A. The importance of natural IgM: scavenger, protector and regulator[J]. Nat Rev Immunol, 2010, 10(11): 778-786. doi:  10.1038/nri2849
[11] SHARP T H, BOYLE A L, DIEBOLDER C A, et al. Insights into IgM-mediated complement activation based on in situ structures of IgM-C1-C4b[J]. Proc Natl Acad Sci USA, 2019, 116(24): 11900-11905. doi:  10.1073/pnas.1901841116
[12] LI Y X, SHEN H, ZHANG R X, et al. Immunoglobulin M perception by FcμR[J]. Nature, 2023, 615(7954): 907-912. doi:  10.1038/s41586-023-05835-w
[13] WU L P, FICKER M, CHRISTENSEN J B, et al. Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking[J]. Nat Commun, 2021, 12(1): 4858. doi:  10.1038/s41467-021-24960-6
[14] MUNSTER P, KROP I E, LORUSSO P, et al. Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study[J]. Br J Cancer, 2018, 119(9): 1086-1093. doi:  10.1038/s41416-018-0235-2
[15] LARGE D E, ABDELMESSIH R G, FINK E A, et al. Liposome composition in drug delivery design, synthesis, characterization, and clinical application[J]. Adv Drug Deliv Rev, 2021, 176: 113851. doi:  10.1016/j.addr.2021.113851
[16] ANTONIOU A I, GIOFRÈ S, SENECI P, et al. Stimulus-responsive liposomes for biomedical applications[J]. Drug Discov Today, 2021, 26(8): 1794-1824. doi:  10.1016/j.drudis.2021.05.010
[17] Barenholz Y. Doxil®--the first FDA-approved nano-drug: lessons learned[J]. Journal of Controlled Release: Official Journal of the Controlled Release Society, 201, 160(2): 117-134.
[18] KRAUSS A C, GAO X, LI L, et al. FDA approval summary:(daunorubicin and cytarabine)liposome for injection for the treatment of adults with high-risk acute myeloid leukemia[J]. Clin Cancer Res, 2019, 25(9): 2685-2690. doi:  10.1158/1078-0432.CCR-18-2990
[19] WANG X C, MOHAMMAD I S, FAN L F, et al. Delivery strategies of amphotericin B for invasive fungal infections[J]. Acta Pharm Sin B, 2021, 11(8): 2585-2604. doi:  10.1016/j.apsb.2021.04.010
[20] WANG H, LIN S, WANG S, et al. Folic acid enables targeting delivery of lipodiscs by circumventing IgM-mediated opsonization[J]. Nano Lett, 2022, 22(16): 6516-6522. doi:  10.1021/acs.nanolett.2c01509
[21] WANG H, DING T H, GUAN J, et al. Interrogation of folic acid-functionalized nanomedicines: the regulatory roles of plasma proteins reexamined[J]. ACS Nano, 2020, 14(11): 14779-14789. doi:  10.1021/acsnano.0c02821
[22] ZHAO Y Z, LU C T. Increasing the entrapment of protein-loaded liposomes with a modified freeze-thaw technique: a preliminary experimental study[J]. Drug Dev Ind Pharm, 2009, 35(2): 165-171. doi:  10.1080/03639040802220300